XML 78 R62.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation Plans (Schedule Of Total Stock Option, Stock Award And PSU Activity) (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Options, Granted 315,555 312,598 326,806
Weighted Average Grant-Date Price, Granted $ 545.69 $ 496.25 $ 482.66
Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Options, Outstanding at January 1, 2020 1,181,154    
Number of Options, Granted 315,555    
Number of Options, Exercised/Vested (370,105)    
Number of Options, Canceled/Forfeited (9,381)    
Number of Options, Outstanding at December 31, 2020 1,117,223 1,181,154  
Number of Options, Vested and expected to vest at December 31, 2020 1,117,223    
Number of Options, Exercisable at December 31, 2020 494,064    
Weighted Average Exercise Price, Outstanding at January 1, 2020 $ 432.75    
Weighted Average Exercise Price, Granted 509.46    
Weighted Average Exercise Price, Exercised/Vested 406.45    
Weighted Average Exercise Price, Canceled/Forfeited 455.42    
Weighted Average Exercise Price, Outstanding at December 31, 2020 462.94 $ 432.75  
Weighted Average Exercise Price, Vested and expected to vest at December 31, 2020 462.94    
Weighted Average Exercise Price, Exercisable at December 31, 2020 $ 437.24    
Weighted Average Remaining Contractual Life (Years), Outstanding at December 31, 2020 3 years 3 months 18 days    
Weighted Average Remaining Contractual Life (Years), Vested and expected to vest at December 31, 2020 3 years 3 months 18 days    
Weighted Average Remaining Contractual Life (Years), Exercisable at December 31, 2020 2 years 2 months 12 days    
Aggregate Intrinsic Value, Outstanding at December 31, 2020 $ 134,531    
Aggregate Intrinsic Value, Vested and expected to vest at December 31, 2020 134,531    
Aggregate Intrinsic Value, Exercisable at December 31, 2020 $ 72,191    
Stock Awards [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Awards, Outstanding at January 1, 2020    
Number of Awards, Granted 2,646    
Number of Awards, Exercised/Vested (2,646)    
Number of Awards, Canceled/ Forfeited    
Number of Awards, Outstanding at December 31, 2020  
Number of Awards, Vested and expected to vest at December 31, 2020    
Weighted Average Grant-Date Price, Outstanding at January 1, 2020    
Weighted Average Grant-Date Price, Granted 545.69    
Weighted Average Grant-Date Price, Exercised/Vested 545.69    
Weighted Average Grant-Date Price, Canceled/Forfeited    
Weighted Average Grant-Date Price, Outstanding at December 31, 2020  
Weighted Average Exercise Price, Vested and expected to vest at December 31, 2020    
Performance Stock Units [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Nonvested Target Units, Outstanding at January 1, 2020 37,490    
Number of Nonvested Target Units, Granted 21,802    
Number of Nonvested Target Units, Exercised/Vested (15,138)    
Number of Nonvested Target Units, Outstanding at December 31, 2020 44,154 37,490  
Number of Nonvested Target Units, Vested and expected to vest at December 31, 2020 49,231    
Weighted Average Grant-Date Price, Outstanding at January 1, 2020 $ 543.11    
Weighted Average Grant-Date Price, Granted 557.23    
Weighted Average Grant-Date Price, Exercised/Vested 544.36    
Weighted Average Grant-Date Price, Outstanding at December 31, 2020 549.65 $ 543.11  
Weighted Average Exercise Price, Vested and expected to vest at December 31, 2020 $ 546.47